Amylin Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a risk mitigation plan for a potential once-weekly diabetes treatment.
FDA asks for risk plan info on diabetes drugCourtesy Newsvine - business Mon, 03/15/2010 - 04:56
Amylin Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a risk mitigation plan for a potential once-weekly diabetes treatment. Tags:
Related itemsUS restricts, EU bans controversial diabetes pill
Diet Treatment, Already in Use, to Get F.D.A. Review
Notable 52-Week Highs and Lows of the Day 02/02:...
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Popular by tags WeekMonth |
Post new comment